Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.

Bhat RM, Vaidya T. Indian dermatology online journal. 2020; 11 (4) : 482-492.
Download PDF
Publication

Role of Histopathology in Predicting type 1 Lepra Reaction in Borderline Tuberculoid Leprosy.

Sankaran D, Sasidharanpillai S, Ajithkumar K, et al. Indian dermatology online journal. 2020; 11 (4) : 586-589.
Download PDF
Publication

A Masquerading Solitary Skin Lesion: Unusual Presentation of Multibacillary Leprosy with Dermoscopic Assistance in Diagnosis.

Kumar Kansal N, Joshi PP, Dhanta A, et al. Indian dermatology online journal. 2020; 11 (4) : 632-634.
Download PDF
Publication

Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile.

van Hooij A, Tió-Coma M, Verhard E, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy.

Tarique M, Naz H, Saini C, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Persistent plaques after release from treatment in slit-skin smear negative leprosy patients: wait and watch or adopt a proactive approach?

Narang T, Bishnoi A, Thakur V, et al. Dermatologic therapy. 2020;
Publication

Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin. Health economic aspects in India

Tiwari A. Erasmus University. Department of Public Health. 2020;
Download PDF
Publication

Ocular erythema nodosum leprosum: An immunohistochemical study

Rathinam S, Parikh J, Rao N. Medknow. Indian Journal of Ophthalmology. 2020; 68 (9) : 2028.
Download PDF
Publication

Anterior chamber angle granuloma: A rare ocular manifestation of histoid lepromatous leprosy

Karkhur S, Soni D, Sharma B. Medknow. Indian Journal of Ophthalmology. 2020; 68 (9) : 2031.
Download PDF
Publication

Ganglionitis and myelitis: myriad neurological manifestations of Hansen's disease.

Bafna P, Sahoo R, Manoj M, et al. BMJ case reports. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 71
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD